Compare McKesson Corporation (MCK) vs PayPal Holdings, Inc. (PYPL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs PayPal Holdings, Inc. — how do they compare? McKesson Corporation trades at $823.62 (market cap $97.35B), while PayPal Holdings, Inc. trades at $55.71 (market cap $50.12B). The key difference: McKesson Corporation is the larger of the two by market cap, and PayPal Holdings, Inc. pays the higher dividend (0.99%). Which is the better fit depends on your goals.
| MCK | PYPL | |
|---|---|---|
Market Cap | $97.35B | $50.12B |
Sector | Health | Financials |
52-Week High | $995.69 | $78.22 |
52-Week Low | $659.01 | $39.08 |
Enterprise Value | $101.98B | $50.19B |
Dividend Yield | 0.39% | 0.99% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
PayPal (PYPL) trades at $56.78, up 0.38% with strong technical momentum as the stock approaches resistance near $57-$59 following a $53 billion takeover bid from Stripe and Advent International. The company shows solid fundamentals with 2025 revenue of $33.17B, net income of $5.23B (15% margin), and attractive valuation metrics including a P/E of 10.6 and P/S of 1.6. Recent earnings beat expectations in Q1 2026 with EPS of $1.34 versus $1.27 expected.
The acquisition offer at $60.50 per share provides near-term upside potential, though the board considers it undervalued. Key risks include regulatory hurdles for the deal and competitive pressures in digital payments. Analyst sentiment is mixed with 36% buy ratings but a consensus price target of $50.80 below current levels, suggesting cautious optimism amid takeover speculation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About PayPal Holdings, Inc.
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →
